Flowcardia - Gilde Healthcare



Murray Hill (NJ), USA

Cardiovascular medical device
Since: 2007
Exit: 2010

FlowCardia is a medical device company marketing catheters that reopen obstructed arteries in the legs, which can avoid amputation. Its lead product, the CROSSER™, uses high-frequency vibration to penetrate hard arterial blockages.

After Gilde led a large institutional financing round of growth capital, the company built a marketing and sales organization, expanded its product portfolio and developed into a high-growth, revenue-generating business. FlowCardia was acquired by C. R. Bard, Inc. (NYSE: BCR) in 2010. It was located in Sunnyvale, California.

More Flowcardia news

Gilde Healthcare II sells its stake in FlowCardia

FlowCardia, Inc. Initiates CENTRAL Study Enrollment

FlowCardia, Inc. expands treatment options for patients with chronic total occlusion

FlowCardia, Inc. Launches FlowMate™ Injector to Optimize Performance

FlowCardia, Inc. Appoints Deborah DeFilippo CFO